What is the initial workup for a patient presenting with new onset hematemesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Workup for New Onset Hematemesis

Immediately assess hemodynamic stability and secure large-bore IV access while simultaneously initiating resuscitation and arranging urgent upper endoscopy within 24 hours of presentation. 1, 2

Immediate Assessment and Stabilization

Hemodynamic Evaluation

  • Assess severity using vital signs and clinical presentation: pulse >100 bpm, systolic BP <100 mmHg, altered mental status, and active hematemesis indicate severe bleeding requiring aggressive intervention 3, 1
  • Measure shock index (heart rate/systolic BP) and pulse pressure to assess hypovolemic shock and transfusion requirements 3, 1
  • Secure two large-bore (ideally 8-Fr) IV cannulae in the anticubital fossae for patients with hemodynamic compromise 3, 1
  • Insert urinary catheter and monitor hourly urine output (target >30 mL/hour) 3

Initial Laboratory Studies

  • Obtain complete blood count, PT, aPTT, and fibrinogen levels immediately 4, 1
  • Do not rely on single hemoglobin/hematocrit measurements alone as isolated markers for bleeding severity, as they lag behind acute blood loss 3, 1
  • Measure serum lactate and base deficit to estimate and monitor the extent of bleeding and tissue hypoperfusion 3, 1
  • Consider near-patient coagulation testing (TEG/ROTEM) if available 1

Resuscitation Strategy

Fluid and Blood Product Administration

  • Initially resuscitate with crystalloids (normal saline or balanced crystalloid) to achieve falling pulse rate, rising BP, and adequate urine output 3, 5
  • Target systolic BP of 80-100 mmHg (MAP 50-60 mmHg) until major bleeding is controlled in patients without brain injury 3, 1, 5
  • Transfuse packed red blood cells when hemoglobin <100 g/L in acute bleeding or when bleeding is extreme with shock 3
  • For patients with cirrhosis and variceal bleeding, maintain hemoglobin target of 70-90 g/L to avoid exacerbating portal pressure 3, 5
  • Avoid fluid overload, which can increase portal pressure and worsen bleeding 3

Pharmacologic Management

  • Administer intravenous proton pump inhibitors immediately in non-variceal upper GI bleeding to decrease high-risk stigmata at endoscopy 2
  • Consider tranexamic acid 10-15 mg/kg followed by infusion of 1-5 mg/kg/h in patients with significant ongoing bleeding 3, 1
  • Administer prokinetic agents 30-60 minutes before endoscopy to improve visualization 2

Diagnostic Workup

Endoscopy Timing and Preparation

  • Perform upper endoscopy within 24 hours of presentation after initial stabilization in most patients 2
  • Urgent endoscopy is indicated for patients with active hematemesis, hemodynamic instability despite resuscitation, or high-risk features 3
  • Endoscopy should only be performed after adequate resuscitation with stable vital signs when possible 3
  • Consider endotracheal intubation before endoscopy in severely bleeding patients to prevent pulmonary aspiration 3
  • Ensure endoscopy is performed by experienced endoscopists capable of therapeutic interventions 3

Additional Imaging

  • Up to 8-11% of patients with hematochezia have an upper GI source, so maintain high suspicion even with lower GI symptoms 3
  • Consider focused sonography (FAST) if significant free fluid or torso trauma is suspected 3
  • CT imaging is reserved for hemodynamically stable patients requiring further anatomic assessment 3

Risk Stratification

High-Risk Features Requiring Intensive Monitoring

  • Age >60 years with hemodynamic compromise 3
  • Pulse >100 bpm, systolic BP <100 mmHg, hemoglobin <100 g/L 3
  • Significant comorbid medical diseases, particularly liver disease 3
  • Active hematemesis or coffee-ground emesis with shock 3
  • Identify patients with liver disease early as they require specific management including restrictive transfusion strategy 3

Lower-Risk Patients

  • Young patients with minor bleeding, no hemodynamic compromise, and no high-risk features may be discharged without immediate endoscopy, with outpatient follow-up arranged 3
  • However, 88% of hematemesis cases stop spontaneously, and only 6% require therapeutic endoscopic intervention 6

Common Pitfalls

  • Avoid delays between presentation and endoscopy in unstable patients, but never perform endoscopy before adequate resuscitation 3, 1
  • Do not rely solely on blood pressure as some patients compensate well despite significant hemorrhage 4, 1
  • Avoid hyperventilation and excessive PEEP in hypovolemic patients as this worsens cardiac output 3, 1
  • Epinephrine injection alone is insufficient for endoscopic hemostasis and must be combined with thermal or mechanical methods 2
  • Consider central venous pressure monitoring in patients with significant cardiac disease to guide fluid replacement 3

References

Guideline

Initial Management of Hematemesis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Non-variceal Upper Gastrointestinal Bleeding and Its Endoscopic Management.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Bleeding 3 Weeks After Miscarriage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cerebrovascular Accident (CVA) Bleed Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.